Healthcare >> CEO Interviews >> June 5, 2000
RONALD J. PRENTKI joined Progenics Pharmaceuticals, Inc. as its
President in July 1998 and became a Director in September 1998. Prior to
joining Progenics, Mr. Prentki had been Vice President of Business
Development and Strategic Planning at Hoffmann-La Roche Inc. from 1996
to 1998. Mr. Prentki spent from 1990 to 1996 at Sterling Winthrop
(subsequently acquired by Sanofi Pharmaceuticals), most recently serving
as Vice President of Business Development. From 1985 to 1990, Mr.
Prentki was with Bristol-Myers Squibb International Division, initially
supporting the marketing of that company's oncology products and later
as Director of Cardiovascular Products. Mr. Prentki started his career
in 1979 in the Ames Diagnostic Division of Miles Laboratories, holding a
series of sales, marketing and product development positions before
leaving Miles Laboratories in 1985. Mr. Prentki received a BS in
Microbiology and Public Health from Michigan State University and an MBA
from the University of Detroit. Profile
Pharmaceuticals, Inc.? Then describe what you see as your company and
business today.
Mr. Prentki: Progenics Pharmaceuticals is a
